SABRIL (vigabatrin) is a prescription medicine made use of with other therapies in children and adults 2 years old and older with refractory complex partial seizures (CPS) that have not responded all right to several various other treatments and if the feasible advantages surpass the risk of vision loss.
It is recommended that your doctor test your (or your child's) vision prior to or within 4 weeks after beginning SABRIL and a minimum of every 3 months throughout therapy until SABRIL is quit. If you or your youngster have any side effect that troubles you or that does not go away, inform your medical care service provider.
If you are expecting or mean to get pregnant, tell your medical care carrier. If vision screening can not be done, your healthcare provider may proceed recommending SABRIL, yet will not be able to expect any kind of vision loss. Your health care supplier may quit prescribing SABRIL for you (or your youngster)if vision tests are not done regularly.